Literature DB >> 9360747

Quality of life in adults and children with asthma and rhinitis.

E F Juniper1.   

Abstract

Many clinicians now recognize the importance of incorporating an assessment of health-related quality of life (HRQL) into their clinical studies and practice. Conventional clinical measures provide valuable information about the status of the affected organ system, but they rarely capture the functional impairments (physical, emotional, and social) that are important to the patients in their everyday lives. In order to obtain a complete picture of a patient's health status, both the conventional clinical indices and the patient's HRQL must be measured. Both adults and children with asthma and rhinitis are distressed by the symptoms, and they are limited in their day-to-day activities such as sports, work or school work, and participation in other activities with friends. In addition, both adults and children experience emotional strain as a result of both conditions. Disease-specific HRQL questionnaires have been developed and validated for both adults and children with asthma and rhinitis. These questionnaires have good measurement properties and validity and can be used in both clinical trials and clinical practice to assess the impact of the condition on a patient's life. Since one of the aims of treatment is to ensure that patients benefit from it, an essential component of clinical assessment should be an evaluation of HRQL.

Entities:  

Mesh:

Year:  1997        PMID: 9360747     DOI: 10.1111/j.1398-9995.1997.tb02416.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  29 in total

1.  Development and validation of a new health-related quality of life instrument for patients with sinusitis.

Authors:  Steven J Atlas; Patricia M Gallagher; Yen A Wu; Daniel E Singer; Richard E Gliklich; Ralph B Metson; Floyd J Fowler
Journal:  Qual Life Res       Date:  2005-06       Impact factor: 4.147

2.  [The association between allergic rhinitis control and sleep quality].

Authors:  R A Gaudin; L P Hoehle; M-A Birkelbach; K M Phillips; A G Beule; D S Caradonna; S T Gray; A R Sedaghat
Journal:  HNO       Date:  2017-12       Impact factor: 1.284

3.  Health-related quality of life and asthma among United States adolescents.

Authors:  Wanjun Cui; Matthew M Zack; Hatice S Zahran
Journal:  J Pediatr       Date:  2014-11-12       Impact factor: 4.406

4.  Factors associated with adolescent and caregiver reported problems in using asthma medications.

Authors:  Betsy Sleath; Delesha M Carpenter; Kathleen E Walsh; Scott A Davis; Claire Hayes Watson; Charles Lee; Ceila E Loughlin; Nacire Garcia; Daniel S Reuland; Gail Tudor
Journal:  J Asthma       Date:  2018-05-21       Impact factor: 2.515

5.  A Computerized Asthma Outcomes Measure Is Feasible for Disease Management.

Authors:  Diane M Turner-Bowker; Renee N Saris-Baglama; Milena Anatchkova; David M Mosen
Journal:  Am J Pharm Benefits       Date:  2010-04-01

Review 6.  Measuring quality of life in paediatric patients.

Authors:  M A Connolly; J A Johnson
Journal:  Pharmacoeconomics       Date:  1999-12       Impact factor: 4.981

7.  Cetirizine: a review of its use in allergic disorders.

Authors:  Monique P Curran; Lesley J Scott; Caroline M Perry
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Lower airway disease in asthmatics with and without rhinitis.

Authors:  Anne E Dixon; Danielle M Raymond; Benjamin T Suratt; Lorraine M Bourassa; Charles G Irvin
Journal:  Lung       Date:  2008-10-09       Impact factor: 2.584

Review 9.  "Not just little adults": qualitative methods to support the development of pediatric patient-reported outcomes.

Authors:  Rob Arbuckle; Linda Abetz-Webb
Journal:  Patient       Date:  2013       Impact factor: 3.883

10.  Effect of high dose inhaled glucocorticoids on quality of life in patients with moderate to severe asthma.

Authors:  Jae-Sung Choi; An-Soo Jang; June-Hyuk Lee; Jong-Sook Park; Sung-Woo Park; Do-Jin Kim; Choon-Sik Park
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.